Introducing Delaware Bio's Board of Directors

Delaware Bio's board is dedicated to ensuring the success of the life science industry in the state of Delaware and the surrounding region ultimately, helping businesses not only survive, but thrive driving innovation in the First State's economy.

OFFICERS

C_Yochim

Chris Yochim

Chairman

H_Stimson

Helen Stimson

President & CEO

M_Bowman

Mike Bowman

Treasurer

P_Amoa

Philip D. Amoa

Secretary

BOARD OF DIRECTORS

I_Bahar

Izak Bahar

Vice President, R&D Assay Development

Siemens Healthineers

Mark-Brainard

Mark T. Brainard, Ph.D.

President

Delaware Technical Community College

P_Cannon

Patricia A. Cannon, MSM, ASZ

Director of Development & FTZ #99 Grantee Administrator

 Delaware Department of State

R_Dashefsky

Richard Dashefsky

Senior Counsel

Christiana Care

K_Griffin
B_Hsu
K_Lee
W_Mongan

Kristin Giffin

Vice President of Operations, Quality, and Support

Agilent Technologies

T. Ben Hsu, Ph.D.

Chief Administrative Officer

QPS Holdings, LLC

Kelvin Lee, Ph.D.

Institute Director

Manufacturing USA National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

William Mongan

Vice President U.S. Business Development, New Product

Planning, and Foundations Brands

AstraZeneca Pharmaceuticals LP

P_Murphy
paula-j-swain.jpg
G_Tronto
r_Yin

Pamela Murphy

Vice President Investor Relations & Corporate Communications (ret),

Incyte Corporation

pICTURE COMING SOON:

Paula J. Swain

Executive Vice President of Human Resources

Incyte Corporation 

Greg Tronto

Gore PharmBio Product Business Development Leader, Drug Delivery

W. L. Gore & Associates, Inc.

Ray Yin, Ph.D.

President

ANP Technologies, Inc.

Blank_silhouette

Fran DiNuzzo

President & CEO

ILC Dover LP

Blank_silhouette

Venu (Kal) Kalavacharla, Ph.D.

Professor, Molecular Genetics and Genomics & Director,

Center for Integrated Biological & Environmental Research (CIBER), Delaware State University